
(Reuters) -Eli Lilly hit $1 trillion in market value on Friday, making it the first drugmaker to enter the exclusive club dominated by tech giants and underscoring its rise as a weight-loss powerhouse.
Here are some reactions to Lilly joining the trillion dollar club:
EVAN SEIGERMAN, ANALYST AT BMO CAPITAL MARKETS
"The current valuation points to investor confidence in the longer-term durability of the company's metabolic health franchise. It also suggests that investors prefer Lilly over Novo in the obesity arms race. Taking a step back, we're also seeing money rotate into the sector as investors may be worried about an AI bubble."
HANK SMITH, DIRECTOR & HEAD OF INVESTMENT STRATEGY AT LILLY SHAREHOLDER HAVERFORD TRUST
"Investors have historically liked secure earnings growth and (Eli Lilly) is the only large cap pharma that has that kind of earnings profile."
(Reporting by Siddhi Mahatole and Shashwat Chauhan in Bengaluru; Editing by Leroy Leo)
latest_posts
- 1
New materials, old physics – the science behind how your winter jacket keeps you warm - 2
Florence's Uffizi Gallery moves treasures to safety after cyberattack - 3
10 Delectable Specialty Mixed drinks - 4
Pick the Ideal Family Feline Variety for Your Home - 5
She was the supermodel dubbed 'The Face' in the '80s. Joining OnlyFans in her 60s taught her a lot.
The Most Encouraging New companies to Look Out For
Hundreds of Gazans evacuated from Strip for medical treatment - COGAT
Picking Your Next SUV: 4 Brands Offering Execution, Solace, and Wellbeing
Woman leaves bachelorette trip after trusting her gut about sketchy men partying it up with friends
A Timeline of Rising Antisemitism in Australia
One dead, six wounded in various crime-related shootings in Israel over the weekend
The most effective method to Involve Handshakes for Compromise and Compromise
Flights canceled at 40 U.S. airports: Follow live updates as FAA cuts to air traffic take effect amid government shutdown
5 Superstar Couples That Motivate Relationship Objectives













